T-Cell Subpopulations and Differentiation Bias in Diabetic and Non-Diabetic Patients with Chronic Kidney Disease

Background: Chronic kidney disease (CKD) patients often experience dysregulated inflammation, particularly when compounded by comorbidities such as type 2 diabetes (T2D). Objective: The aim of this study was to determine whether T2D influences the profile of memory T lymphocytes, regulatory T cells...

Full description

Saved in:
Bibliographic Details
Main Authors: Ana Cecilia Granda Alacote, Gabriela Goyoneche Linares, María Gracia Castañeda Torrico, Daysi Zulema Diaz-Obregón, Michael Bryant Castro Núñez, Alexis Germán Murillo Carrasco, Cesar Liendo Liendo, Katherine Susan Rufasto Goche, Víctor Arrunátegui Correa, Joel de León Delgado
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/13/1/3
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832589061100929024
author Ana Cecilia Granda Alacote
Gabriela Goyoneche Linares
María Gracia Castañeda Torrico
Daysi Zulema Diaz-Obregón
Michael Bryant Castro Núñez
Alexis Germán Murillo Carrasco
Cesar Liendo Liendo
Katherine Susan Rufasto Goche
Víctor Arrunátegui Correa
Joel de León Delgado
author_facet Ana Cecilia Granda Alacote
Gabriela Goyoneche Linares
María Gracia Castañeda Torrico
Daysi Zulema Diaz-Obregón
Michael Bryant Castro Núñez
Alexis Germán Murillo Carrasco
Cesar Liendo Liendo
Katherine Susan Rufasto Goche
Víctor Arrunátegui Correa
Joel de León Delgado
author_sort Ana Cecilia Granda Alacote
collection DOAJ
description Background: Chronic kidney disease (CKD) patients often experience dysregulated inflammation, particularly when compounded by comorbidities such as type 2 diabetes (T2D). Objective: The aim of this study was to determine whether T2D influences the profile of memory T lymphocytes, regulatory T cells (Tregs), and the gene expression of transcription factors such as <i>T-bet (Tbx21)</i>, <i>GATA3</i>, <i>RORyT (RORC)</i>, and <i>FOXP3</i> in CKD patients. Methods: Twenty-two CKD patients undergoing hemodialysis were selected for the study. Flow cytometry was used to identify naïve T cells, Tregs (CD4+CD25+CD127-), central memory T lymphocytes (CCR7+CD45RA-), effector memory T lymphocytes (CCR7-CD45RA-), and TEMRA cells (CCR7-CD45RA+). The expression of helper T cell differentiation regulatory genes was assessed using real-time RT-PCR. Results: Both helper and cytotoxic effector memory T cell populations were found to be higher than naïve lymphocytes in CKD patients, regardless of T2D status. However, Tregs were significantly more frequent in diabetic CKD patients (5.1 ± 2.6%) compared to non-diabetic patients (2.8 ± 3.1%). In terms of transcription factor expression, a significant correlation was observed between T-bet and <i>FOXP3</i> in diabetic patients, and between RORyT and FOXP3 in non-diabetic patients. Conclusions: While T2D does not notably alter the distribution of memory T cells in CKD patients, it significantly impacts the frequency of Tregs and their correlation with pro-inflammatory transcription factors like <i>T-bet (Tbx21)</i> and <i>RORyT</i>.
format Article
id doaj-art-9ba17252595d4a218263948403e1aabd
institution Kabale University
issn 2227-9059
language English
publishDate 2024-12-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj-art-9ba17252595d4a218263948403e1aabd2025-01-24T13:23:41ZengMDPI AGBiomedicines2227-90592024-12-01131310.3390/biomedicines13010003T-Cell Subpopulations and Differentiation Bias in Diabetic and Non-Diabetic Patients with Chronic Kidney DiseaseAna Cecilia Granda Alacote0Gabriela Goyoneche Linares1María Gracia Castañeda Torrico2Daysi Zulema Diaz-Obregón3Michael Bryant Castro Núñez4Alexis Germán Murillo Carrasco5Cesar Liendo Liendo6Katherine Susan Rufasto Goche7Víctor Arrunátegui Correa8Joel de León Delgado9Faculty of Natural Sciences and Mathematics, Universidad Nacional Federico Villarreal, Lima 15001, PeruFaculty of Natural Sciences and Mathematics, Universidad Nacional Federico Villarreal, Lima 15001, PeruONG Innovation and Science for the Care and Support of Society–INNOVACARE, Lima 15036, PeruHealth Technology Assessment and Research Institute-EsSalud, Lima 15072, PeruFaculty of Medicine, Universidad Nacional Federico Villarreal, Lima 15001, PeruImmunology and Cancer Research Group-IMMUCA, Lima 15001, PeruNephrology Center-CENESA, Lima 15001, PeruPostgraduate School, Universidad Nacional Federico Villarreal, Lima 15001, PeruFaculty of Human Medicine, University of San Martín de Porres, Lima 15011, PeruCenter of Virology Research, Faculty of Human Medicine, University of San Martín de Porres, Lima 15011, PeruBackground: Chronic kidney disease (CKD) patients often experience dysregulated inflammation, particularly when compounded by comorbidities such as type 2 diabetes (T2D). Objective: The aim of this study was to determine whether T2D influences the profile of memory T lymphocytes, regulatory T cells (Tregs), and the gene expression of transcription factors such as <i>T-bet (Tbx21)</i>, <i>GATA3</i>, <i>RORyT (RORC)</i>, and <i>FOXP3</i> in CKD patients. Methods: Twenty-two CKD patients undergoing hemodialysis were selected for the study. Flow cytometry was used to identify naïve T cells, Tregs (CD4+CD25+CD127-), central memory T lymphocytes (CCR7+CD45RA-), effector memory T lymphocytes (CCR7-CD45RA-), and TEMRA cells (CCR7-CD45RA+). The expression of helper T cell differentiation regulatory genes was assessed using real-time RT-PCR. Results: Both helper and cytotoxic effector memory T cell populations were found to be higher than naïve lymphocytes in CKD patients, regardless of T2D status. However, Tregs were significantly more frequent in diabetic CKD patients (5.1 ± 2.6%) compared to non-diabetic patients (2.8 ± 3.1%). In terms of transcription factor expression, a significant correlation was observed between T-bet and <i>FOXP3</i> in diabetic patients, and between RORyT and FOXP3 in non-diabetic patients. Conclusions: While T2D does not notably alter the distribution of memory T cells in CKD patients, it significantly impacts the frequency of Tregs and their correlation with pro-inflammatory transcription factors like <i>T-bet (Tbx21)</i> and <i>RORyT</i>.https://www.mdpi.com/2227-9059/13/1/3chronic kidney diseasetype 2 diabetestranscription factorsT cells
spellingShingle Ana Cecilia Granda Alacote
Gabriela Goyoneche Linares
María Gracia Castañeda Torrico
Daysi Zulema Diaz-Obregón
Michael Bryant Castro Núñez
Alexis Germán Murillo Carrasco
Cesar Liendo Liendo
Katherine Susan Rufasto Goche
Víctor Arrunátegui Correa
Joel de León Delgado
T-Cell Subpopulations and Differentiation Bias in Diabetic and Non-Diabetic Patients with Chronic Kidney Disease
Biomedicines
chronic kidney disease
type 2 diabetes
transcription factors
T cells
title T-Cell Subpopulations and Differentiation Bias in Diabetic and Non-Diabetic Patients with Chronic Kidney Disease
title_full T-Cell Subpopulations and Differentiation Bias in Diabetic and Non-Diabetic Patients with Chronic Kidney Disease
title_fullStr T-Cell Subpopulations and Differentiation Bias in Diabetic and Non-Diabetic Patients with Chronic Kidney Disease
title_full_unstemmed T-Cell Subpopulations and Differentiation Bias in Diabetic and Non-Diabetic Patients with Chronic Kidney Disease
title_short T-Cell Subpopulations and Differentiation Bias in Diabetic and Non-Diabetic Patients with Chronic Kidney Disease
title_sort t cell subpopulations and differentiation bias in diabetic and non diabetic patients with chronic kidney disease
topic chronic kidney disease
type 2 diabetes
transcription factors
T cells
url https://www.mdpi.com/2227-9059/13/1/3
work_keys_str_mv AT anaceciliagrandaalacote tcellsubpopulationsanddifferentiationbiasindiabeticandnondiabeticpatientswithchronickidneydisease
AT gabrielagoyonechelinares tcellsubpopulationsanddifferentiationbiasindiabeticandnondiabeticpatientswithchronickidneydisease
AT mariagraciacastanedatorrico tcellsubpopulationsanddifferentiationbiasindiabeticandnondiabeticpatientswithchronickidneydisease
AT daysizulemadiazobregon tcellsubpopulationsanddifferentiationbiasindiabeticandnondiabeticpatientswithchronickidneydisease
AT michaelbryantcastronunez tcellsubpopulationsanddifferentiationbiasindiabeticandnondiabeticpatientswithchronickidneydisease
AT alexisgermanmurillocarrasco tcellsubpopulationsanddifferentiationbiasindiabeticandnondiabeticpatientswithchronickidneydisease
AT cesarliendoliendo tcellsubpopulationsanddifferentiationbiasindiabeticandnondiabeticpatientswithchronickidneydisease
AT katherinesusanrufastogoche tcellsubpopulationsanddifferentiationbiasindiabeticandnondiabeticpatientswithchronickidneydisease
AT victorarrunateguicorrea tcellsubpopulationsanddifferentiationbiasindiabeticandnondiabeticpatientswithchronickidneydisease
AT joeldeleondelgado tcellsubpopulationsanddifferentiationbiasindiabeticandnondiabeticpatientswithchronickidneydisease